PROSPECTS OF USING ANTI-IDIOTYPIC ANTIBODIES TO TWO MORPHINE DERIVATIVES IN THE FORM OF LIPOSOMAL FORM FOR THE DEVELOPMENT OF A VACCINE AGAINST OPIATE ADDICTION